CD79A and B-cell chronic lymphocytic leukemia: In this study, we have demonstrated that HSP90 is overexpressed in CLL cells that controls key signal mediators of the BCR pathway including CD79a, BCAP, PLCγ2, LYN, SYK, BTK and AKT.